Pembrolizumab As Second or Further Line Treatment in Relapsed Malignant Pleural Mesothelioma: A Swiss RegistryL. A. Mauti,D. Klingbiel,S. Schmid,H. Bouchaab, T. Bartnick,O. Gautschi,S. I. Rothschild, M. Loeffler,P. Froesch,U. Petrausch,S. Wolleb Schild,W. Mingrone, S. Pratsch Peter,S. Savic Prince,M. Pless,R. von Moos,Y. MetaxasAnnals of oncology(2017)引用 4|浏览80暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要